Invest now

Morepen Laboratories Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
58.95 -1.86 (-3.06%)Updated : 17 Jul 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 1,690.671,666.491,565.281,365.93
Other Net 21.3111.2411.474.48
Diluted Weighted Average Shares 54.8453.5351.1250.22
Depreciation/ Amortization 36.4328.9833.4727.93
Operating Income 115.02145.09125.1651.60
Net Income 94.88118.0296.1638.68
Income Availableto Com Excl Extra Ord 94.88118.0296.1638.68
Other Operating Expenses Total 156.71118.07141.5870.86
Net Income Before Taxes 119.92155.11135.4255.76
Minority Interest -0.770.01-0.460.00
Net Income After Taxes 95.65118.0296.6238.68
Income Availableto Com Incl Extra Ord 94.88118.0296.1638.68
Costof Revenue Total 1,168.311,226.301,117.61994.15
Gross Profit 637.38585.28572.82423.38
Interest Inc( Exp) Net- Non- Op Total -16.41-1.22-1.21-0.32
Unusual Expense( Income) -25.83---
Diluted Net Income 94.88118.0296.1638.68
DPS- Common Stock Primary Issue 0.200.20--
Provisionfor Income Taxes 24.2737.0938.8017.08
period Type ----
Net Income Before Extra Items 94.88118.0296.1638.68
Total Revenue 1,805.691,811.581,690.431,417.53
period Length 12.0012.0012.0012.00
Revenue 1,805.691,811.581,690.431,417.53
Selling/ General/ Admin Expenses Total 355.04289.44267.42269.92
Diluted Normalized EPS 1.352.201.880.77
Diluted EPS Excluding Extra Ord Items 1.732.201.880.77
Research Development -3.695.203.07
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,570.50+59.15(3.91%)
2,840.00-19.55 (-0.68%)